Another interesting observation was that leptin therapy led to the attenuation of circulating glucose insulinotropic peptide (GIP) levels and an increase in ghrelin levels in individuals with MASH who had no formal diagnosis of lipodystrophy but relative leptin deficiency [18]. This evidence concerns the gene GIP and metabolic dysfunction-associated steatohepatitis.